Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.

Content Provider	Europe PMC
Author	Yoshino, Takayuki Andre, Thierry Kim, Tae Won Yong, Wei Peng Shiu, Kai‐Keen Jensen, Benny Vittrup Jensen, Lars Henrik Punt, Cornelis J. A. Smith, Denis Garcia‐Carbonero, Rocio Alcaide‐Garcia, Julia Gibbs, Peter de la Fouchardiere, Christelle Rivera, Fernando Elez, Elena Le, Dung T. Adachi, Noriaki Fogelman, David Marinello, Patricia Diaz, Luis A.
Page Count	11
ISSN	13479032
Volume Number	114
PubMed Central reference number	PMC9986093
Issue Number	3
PubMed reference number	36369901
Journal	Cancer Science [Cancer Sci]
e-ISSN	13497006
DOI	10.1111/cas.15650
Language	English
Publisher	John Wiley and Sons Inc.
Publisher Date	2022-12-12
Publisher Place	Hoboken
Access Restriction	Open
Rights License	This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2022 Merck Sharp & Dohme LLC and The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Subject Keyword	Asia colorectal cancer microsatellite instability mismatch‐repair deficiency pembrolizumab
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology